Bioresorbable polymer coated drug eluting stent: a model study.

In drug eluting stent technologies, an increased demand for better control, higher reliability, and enhanced performances of drug delivery systems emerged in the last years and thus offered the opportunity to introduce model-based approaches aimed to overcome the remarkable limits of trial-and-error methods. In this context a mathematical model was studied, based on detailed conservation equations and taking into account the main physical-chemical mechanisms involved in polymeric coating degradation, drug release, and restenosis inhibition. It allowed highlighting the interdependence between factors affecting each of these phenomena and, in particular, the influence of stent design parameters on drug antirestenotic efficacy. Therefore, the here-proposed model is aimed to simulate the diffusional release, for both in vitro and the in vivo conditions: results were verified against various literature data, confirming the reliability of the parameter estimation procedure. The hierarchical structure of this model also allows easily modifying the set of equations describing restenosis evolution to enhance model reliability and taking advantage of the deep understanding of physiological mechanisms governing the different stages of smooth muscle cell growth and proliferation. In addition, thanks to its simplicity and to the very low system requirements and central processing unit (CPU) time, our model allows obtaining immediate views of system behavior.

[1]  W L Hunter,et al.  Solid-state characterization of paclitaxel. , 1997, Journal of pharmaceutical sciences.

[2]  S. Venkatraman,et al.  Paclitaxel release from single and double-layered poly(DL-lactide-co-glycolide)/poly(L-lactide) film for biodegradable coronary stent application. , 2008, Journal of biomedical materials research. Part A.

[3]  J Wouter Jukema,et al.  Drug-eluting stents: results, promises and problems. , 2005, International journal of cardiology.

[4]  Suncica Canic,et al.  Mathematical Modeling of Vascular Stents * , 2010 .

[5]  F. Alexis Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)] , 2005 .

[6]  Elazer R Edelman,et al.  Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Caitríona Lally,et al.  Determination of the influence of stent strut thickness using the finite element method: implications for vascular injury and in-stent restenosis , 2009, Medical & Biological Engineering & Computing.

[8]  P. Zunino,et al.  A Numerical Study of the Interaction of Blood Flow and Drug Release from Cardiovascular Stents , 2008 .

[9]  G. Golomb,et al.  Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosis. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[10]  F. Tondato,et al.  Toxic vessel reaction to an absorbable polymer-based paclitaxel-eluting stent in pig coronary arteries. , 2006, The Journal of invasive cardiology.

[11]  Patrick W Serruys,et al.  Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy , 2004, The Lancet.

[12]  Suming Li,et al.  Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. , 1995, Biomaterials.

[13]  T. Fojo,et al.  Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity , 2001, Oncogene.

[14]  E. Duek,et al.  Use of triethylcitrate plasticizer in the production of poly-L-lactic acid implants with different degradation times , 2003, Journal of materials science. Materials in medicine.

[15]  M. Fillinger,et al.  Effect of endothelial cells and transforming growth factor-beta 1 on cultured vascular smooth muscle cell growth patterns. , 1994, Journal of vascular surgery.

[16]  V. Busini,et al.  Mechanistic modelling of avascular tumor growth and pharmacokinetics influence—Part I , 2007 .

[17]  Mary E. Russell,et al.  Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. , 2005 .

[18]  H. Burt,et al.  Drug-eluting stents: factors governing local pharmacokinetics. , 2006, Advanced drug delivery reviews.

[19]  B. Tesfamariam Drug Release Kinetics From Stent Device-Based Delivery Systems , 2008, Journal of cardiovascular pharmacology.

[20]  New Frontiers in Cardiology Drug-Eluting Stents: Part II Clinical Cardiology: New Frontiers , 2022 .

[21]  Michel Vert,et al.  Biodegradable polymers and plastics , 1992 .

[22]  M. Böhm,et al.  Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. , 2003, Journal of the American College of Cardiology.

[23]  Patrick W Serruys,et al.  New frontiers in cardiology: drug-eluting stents: Part I. , 2003, Circulation.

[24]  S. Yalkowsky,et al.  Solubilization of rapamycin. , 2001, International journal of pharmaceutics.

[25]  H. Tsuji,et al.  Alkaline and enzymatic degradation of L‐lactide copolymers. II. Crystallized films of poly(L‐lactide‐co‐D‐lactide) and poly(L‐lactide) with similar crystallinities , 2005 .

[26]  G. Golomb,et al.  A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Chad Johnson,et al.  The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. , 2004, Biomaterials.

[28]  Ruediger C. Braun-Dullaeus,et al.  Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies , 2002, Nature Medicine.

[29]  Luca Formaggia,et al.  MODELING POLYMERIC CONTROLLED DRUG RELEASE AND TRANSPORT PHENOMENA IN THE ARTERIAL TISSUE , 2010 .

[30]  G. Perale,et al.  A new model of resorbable device degradation and drug release: transient 1-dimension diffusional model. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[31]  Sanjay Pant,et al.  Geometry parameterization and multidisciplinary constrained optimization of coronary stents , 2011, Biomechanics and Modeling in Mechanobiology.

[32]  L. Buellesfeld,et al.  BioMatrix® Biolimus A9®-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease , 2006, Expert review of medical devices.

[33]  Kumbakonam R. Rajagopal,et al.  Modeling the response of nonlinear viscoelastic biodegradable polymeric stents , 2012 .

[34]  A. Göpferich,et al.  Why degradable polymers undergo surface erosion or bulk erosion. , 2002, Biomaterials.

[35]  G Dubini,et al.  Modelling drug elution from stents: effects of reversible binding in the vascular wall and degradable polymeric matrix , 2008, Computer methods in biomechanics and biomedical engineering.

[36]  J. Parikh,et al.  Mechanism and in Vitro Release Kinetic Study of Sirolimus from a Biodegradable Polymeric Matrix Coated Cardiovascular Stent , 2011 .

[37]  S. Hossainy,et al.  A theoretical model to characterize the drug release behavior of drug-eluting stents with durable polymer matrix coating. , 2012, Journal of biomedical materials research. Part A.

[38]  CHRISTIAN VERGARA,et al.  Multiscale Boundary Conditions for Drug Release from Cardiovascular Stents , 2008, Multiscale Model. Simul..

[39]  G. Perale,et al.  Drug eluting sutures: a model for in vivo estimations. , 2012, International journal of pharmaceutics.

[40]  E. Edelman,et al.  Liposomal Alendronate Inhibits Systemic Innate Immunity and Reduces In-Stent Neointimal Hyperplasia in Rabbits , 2003, Circulation.

[41]  S. Hossainy,et al.  Modeling of degradation and drug release from a biodegradable stent coating. , 2007, Journal of biomedical materials research. Part A.

[42]  X. Zhu,et al.  Physical models of diffusion for polymer solutions, gels and solids , 1999 .

[43]  Suming Li,et al.  Enzymatic degradation of block copolymers obtained by sequential ring opening polymerization of l-lactide and ɛ-caprolactone , 2007 .

[44]  B. Xu,et al.  In vitro and in vivo changes to PLGA/sirolimus coating on drug eluting stents. , 2010, Biomaterials.

[45]  S. Hossainy,et al.  A mathematical model for predicting drug release from a biodurable drug-eluting stent coating. , 2008, Journal of biomedical materials research. Part A.

[46]  L. Khachigian,et al.  Recent developments in drug-eluting stents , 2011, Journal of Molecular Medicine.

[47]  J. Davies,et al.  In vitro degradation of a novel poly(lactide-co-glycolide) 75/25 foam. , 1999, Biomaterials.

[48]  Giuseppe Perale,et al.  A new model of resorbable device degradation and drug release - part I: zero order model , 2008 .

[49]  G. Golomb,et al.  Route of administration-dependent anti-inflammatory effect of liposomal alendronate. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[50]  R. Gaynor,et al.  The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β , 1998, Nature.

[51]  J. Liao,et al.  Inhibition of Vascular Smooth Muscle Cell Proliferation by Sodium Salicylate Mediated by Upregulation of p21Waf1 and p27Kip1 , 2000, Circulation.

[52]  S. Hill,et al.  Cellular uptake profile of paclitaxel using liquid chromatography tandem mass spectrometry. , 1998, Rapid communications in mass spectrometry : RCM.

[53]  Francesco Migliavacca,et al.  Model Reduction Strategies Enable Computational Analysis of Controlled Drug Release from Cardiovascular Stents , 2011, SIAM J. Appl. Math..

[54]  K. Na,et al.  An acetylated polysaccharide-PTFE membrane-covered stent for the delivery of gemcitabine for treatment of gastrointestinal cancer and related stenosis. , 2011, Biomaterials.

[55]  Brad S. Hubbard,et al.  In Vitro and In Vivo Characterization of Novel Biodegradable Polymers for Application as Drug-Eluting Stent Coatings , 2010, Journal of biomaterials science. Polymer edition.

[56]  David Martin,et al.  Computational structural modelling of coronary stent deployment: a review , 2011, Computer methods in biomechanics and biomedical engineering.

[57]  A. Mikos,et al.  In vitro degradation of thin poly(DL-lactic-co-glycolic acid) films. , 1999, Journal of biomedical materials research.

[58]  H. Tsuji,et al.  Alkaline and enzymatic degradation of L-lactide copolymers, 1. Amorphous-made films of L-lactide copolymers with D-lactide, glycolide, and epsilon-caprolactone. , 2005, Macromolecular bioscience.

[59]  Gregg W Stone,et al.  Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. , 2005, JAMA.

[60]  Gerhard A. Holzapfel,et al.  A Numerical Model to Study the Interaction of Vascular Stents with Human Atherosclerotic Lesions , 2007, Annals of Biomedical Engineering.

[61]  Y. Weng,et al.  Preparation and characterization of rapamycin-loaded PLGA coating stent , 2007, Journal of materials science. Materials in medicine.

[62]  E. Edelman,et al.  Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[63]  J. S. Vrentas,et al.  Diffusion in glassy polymers , 2003 .

[64]  H. Kroemer,et al.  Examination of drug release and distribution from drug-eluting stents with a vessel-simulating flow-through cell. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[65]  A. Tzafriri,et al.  Luminal flow patterns dictate arterial drug deposition in stent-based delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[66]  R. Falotico,et al.  Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries. , 2005, European journal of pharmacology.

[67]  A. Göpferich,et al.  Mechanisms of polymer degradation and erosion. , 1996, Biomaterials.

[68]  Lei Lei,et al.  Stents as a platform for drug delivery , 2011, Expert opinion on drug delivery.

[69]  Francesco Migliavacca,et al.  Hemodynamics and In-stent Restenosis: Micro-CT Images, Histology, and Computer Simulations , 2011, Annals of Biomedical Engineering.

[70]  Kinam Park,et al.  Mechanisms of controlled drug release from drug-eluting stents. , 2006, Advanced drug delivery reviews.

[71]  Dimitris Karnabatidis,et al.  Computational representation and hemodynamic characterization of in vivo acquired severe stenotic renal artery geometries using turbulence modeling. , 2008, Medical engineering & physics.

[72]  A. Kastrati,et al.  Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study. , 2010, Journal of the American College of Cardiology.

[73]  F. Boey,et al.  Release profiles in drug-eluting stents: issues and uncertainties. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[74]  R. Virmani,et al.  Drug-eluting stents: caution and concerns for long-term outcome , 2004, Coronary artery disease.

[75]  S. Venkatraman,et al.  Adjustable paclitaxel release kinetics and its efficacy to inhibit smooth muscle cells proliferation. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[76]  E. Edelman,et al.  Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. , 2000, Journal of the American College of Cardiology.

[77]  B. Buchholz,et al.  In vitro and in vivo degradation of poly(D, L-lactide-co-glycolide)/amorphous calcium phosphate copolymer coated on metal stents. , 2011, Journal of biomedical materials research. Part A.

[78]  H. Uehata,et al.  Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. , 2000, Circulation.

[79]  L. P. Tan,et al.  Effect of plasticization on heparin release from biodegradable matrices. , 2004, International journal of pharmaceutics.

[80]  Jong-Chul Park,et al.  Underlying mechanism for suppression of vascular smooth muscle cells by green tea polyphenol EGCG released from biodegradable polymers for stent application. , 2010, Journal of biomedical materials research. Part A.

[81]  A. Greiner,et al.  Poly(ethylene carbonate): a thermoelastic and biodegradable biomaterial for drug eluting stent coatings? , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[82]  A. Albertsson,et al.  Enzymatic degradation of monolayer for poly(lactide) revealed by real-time atomic force microscopy: effects of stereochemical structure, molecular weight, and molecular branches on hydrolysis rates. , 2008, Biomacromolecules.